1. Introduction
===============

Acridine derivatives were primarily used as stains for dye manufacturing (e.g., acridine orange) until their fluorescence and chemiluminescence properties found numerous other applications \[[@B1-molecules-18-01613],[@B2-molecules-18-01613],[@B3-molecules-18-01613]\]. Such acridines have demonstrated important biological activity \[[@B4-molecules-18-01613]\], including activity against cancer \[[@B5-molecules-18-01613]\] due to their ability to intercalate into DNA and disrupt unwanted cellular processes \[[@B6-molecules-18-01613]\]. This unique property of acridines has been exploited in many areas of medicine. As a result, significant biological activity toward viruses \[[@B7-molecules-18-01613]\], bacteria \[[@B8-molecules-18-01613]\], parasites \[[@B9-molecules-18-01613],[@B10-molecules-18-01613]\], fungus \[[@B11-molecules-18-01613]\], Alzheimer's disease \[[@B12-molecules-18-01613]\], and HIV/AIDS \[[@B13-molecules-18-01613]\] has also been reported. Pyrrolo\[2,3,4-*kl*\]acridine derivatives have been isolated from a *Plakortis* sponge and showed biological activities \[[@B14-molecules-18-01613],[@B15-molecules-18-01613]\]. Although there have been some reports on the synthesis of these molecules \[[@B16-molecules-18-01613],[@B17-molecules-18-01613]\], those methods require multistep syntheses. Recently, we \[[@B18-molecules-18-01613]\] and Tu \[[@B19-molecules-18-01613]\] reported the one-pot synthesis of pyrrolo\[2,3,4-*kl*\]acridine derivatives catalyzed by L-proline or AcOH, respectively. However, these methods required the use of toluene or acetic acid as solvents. Thus, there is a need for the development of concise and green methods for the construction of this heterocyclic skeleton.

The need to reduce the amount of toxic waste and by-product arising from chemical process requires increasing emphasis on the use of less toxic and environmentally compatible materials in the design of new synthetic methods. One of the most promising approaches in organic synthesis is the use of reusable heterogeneous catalysts because of their environmental, economical, and industrial aspects \[[@B20-molecules-18-01613]\]. The development of efficient methods using recoverable and reusable catalysts is an important goal in organic synthesis. Up to now, several reusable and heterogeneous catalysts have been designed and used. One useful example is silica sulfuric acid (SSA), which has been widely studied in recent years \[[@B21-molecules-18-01613],[@B22-molecules-18-01613],[@B23-molecules-18-01613]\], in a variety of reactions such as cross-Aldol condensation \[[@B24-molecules-18-01613]\], deacylation \[[@B25-molecules-18-01613]\], selective oxidation \[[@B26-molecules-18-01613]\], Michael addition \[[@B27-molecules-18-01613]\] and functional group protection \[[@B28-molecules-18-01613]\]. In our previous works, SSA was used as an efficient catalyst for the acetylation of aldehydes and sugars \[[@B29-molecules-18-01613]\]. As a continuation of our interest in organic reactions catalyzed by solid acids \[[@B29-molecules-18-01613],[@B30-molecules-18-01613]\], herein, we report the microwave-assisted green synthesis of pyrrolo\[2,3,4-*kl*\]acridine-1-one derivatives catalyzed by SSA in ethanol.

2. Results and Discussion
=========================

In a preliminary study, we optimized the reaction conditions, including reaction solvents, temperature, catalyst and amount of SSA catalyst using isatin (**1a**), and 3-(4-*t*-butylphenylamino)-5,5-dimethylcyclohex-2-enone (**2a**) as model reactants ([Scheme 1](#molecules-18-01613-f002){ref-type="scheme"}). The reaction mixture, which was composed of a 1:1 mixture of **1a** to **2a**, was tested under different conditions. The results are summarized in [Table 1](#molecules-18-01613-t001){ref-type="table"}.

![The model reaction.](molecules-18-01613-g002){#molecules-18-01613-f002}

molecules-18-01613-t001_Table 1

###### 

Optimization of the reaction conditions for the synthesis of **3a**.

  Entry   Solvent           Catalyst              T (°C)   Time (min)   Yield ^a^ (%)
  ------- ----------------- --------------------- -------- ------------ ---------------
  1       ethanol           \-                    110      15           23
  2       ethanol           SSA (0.02 g)          110      15           91
  3       AcOH              SSA (0.02 g)          110      15           85
  4       H~2~O             SSA (0.02 g)          110      15           81
  5       ethylene glycol   SSA (0.02 g)          110      15           87
  6       toluene           SSA (0.02 g)          110      15           91
  7       ethanol           HCl (0.5 mL)          110      15           78
  8       ethanol           H~2~SO~4~ (0.5 mL)    110      15           59
  9       ethanol           I~2~ (0.02 g)         110      15           73
  10      ethanol           L-proline (10 mol%)   110      15           40
  11      ethanol           SSA (0.03 g)          110      15           90
  12      ethanol           SSA (0.04 g)          110      15           91
  13      ethanol           SSA (0.01 g)          110      15           76
  14      ethanol           SSA (0.02 g)          90       15           71
  15      ethanol           SSA (0.02 g)          100      15           85
  16      ethanol           SSA (0.02 g)          120      15           87
  17      ethanol           SSA (0.02 g)          110      8            77
  18      ethanol           SSA (0.02 g)          110      10           87
  19      ethanol           SSA (0.02 g)          110      12           91
  20      ethanol           SSA (0.02 g)          110      20           89

^a^ Yield was determined by HPLC-MS.

The optimization process revealed that the reactions did not proceed in ethanol under catalyst-free conditions ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 1). Pleasingly, the target compound **3a** was obtained in ethanol with 0.02 g SSA as catalyst ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 2). To improve the yield, different solvents were evaluated. The results indicated that ethanol provided much better results than AcOH, ethylene glycol or water ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entries 2--5). The non-polar solvent toluene gave the same yield ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 6). Considering the toxicity of toluene, ethanol was selected as the preferred reaction solvent. Several other catalysts were also evaluated for their catalytic efficiency in the current reaction. Common acids (H~2~SO~4~ and HCl) and other catalysts (I~2~ or L-proline) can catalyze this reaction with low yields ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entries 7--10). The results revealed that SSA was the optimal catalyst with the product being isolated in 91% yield ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 2). Subsequently, we proceeded to evaluate the amount of SSA required for this reaction. When 0.02 g of silica gel was used, the reaction of **3a** proceeded in good yield (91%, [Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 2). The reaction yield remained unchanged when we increased the amount of SSA ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entries 11 and 12), but the yield was lower when the amount of SSA was decreased ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 13), therefore, 0.02 g of SSA is sufficient to initiate the reaction. To identify the optimum reaction temperature, the reaction was carried out with 0.02 g SSA at 90 °C, 100 °C, 110 °C and 120 °C, providing the product **3a** in yields of 71%, 85%, 91% and 87% ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entries 14, 15, 2 and 16), respectively, so the most suitable reaction temperature for this reaction is 110 °C. Finally, to optimize the reaction time, the reaction was carried out with 0.02 g SSA at 110 °C and the reaction time used was 8 min, 10 min, 12 min, 15 min and 20 min, respectively. It was found that the reaction can proceed smoothly in 12 min ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entry 19), while prolonging the reaction time did not enhance the yield of the product ([Table 1](#molecules-18-01613-t001){ref-type="table"}, entries 2 and 20). Thus, the optimum conditions required the use of 0.02 g SSA as catalyst in ethanol as solvent at 110 °C and a reaction time of 12 min.

Having established the optimal conditions we proceeded to investigate the substrate scope of the transformation. As shown in [Table 2](#molecules-18-01613-t002){ref-type="table"}, substituents such as bromo, chloro, fluoro on the isatin ring, and *t*-butyl or phenyl groups bearing either electron-withdrawing or electron-donating groups on the enaminone ring, were well tolerated under these reaction conditions, leading to the final products in satisfactory yields (up to 93%).

molecules-18-01613-t002_Table 2

###### 

Synthesis of dihydropyrrolo\[2,3,4-*kl*\]acridines **3**.

  Entry   Product   R~1~   R~2~                     Time (min)   Isolated Yield (%)
  ------- --------- ------ ------------------------ ------------ --------------------
  1       **3a**    H      4-*t*-BuC~6~H~4~         12           91
  2       **3b**    H      3,5-(CH~3~)~2~C~6~H~3~   12           92
  3       **3c**    H      2-CH~3~CH~2~C~6~H~4~     12           92
  4       **3d**    H      3-Cl-4-FC~6~H~3~         15           89
  5       **3e**    5-Cl   4-CH~3~OC~6~H~4~         12           90
  6       **3f**    5-Cl   4-*t*-BuC~6~H~4~         12           91
  7       **3g**    5-Cl   3,5-(CH~3~)~2~C~6~H~3~   12           92
  8       **3h**    5-Cl   3-Cl-4-FC~6~H~3~         15           90
  9       **3i**    5-Cl   2-CH~3~CH~2~C~6~H~4~     12           93
  10      **3j**    5-Cl   *n*-C~4~H~9~             15           89
  11      **3k**    5-F    4-CH~3~C~6~H~4~          12           92
  12      **3l**    5-F    4-ClC~6~H~4~             12           91
  13      **3m**    5-F    2,4-(CH~3~)~2~C~6~H~3~   12           91
  14      **3n**    5-F    3-Cl-4-FC~6~H~3~         15           90
  15      **3o**    5-F    4-*t*-BuC~6~H~4~         12           92
  16      **3p**    5-F    2-CH~3~CH~2~C~6~H~4~     12           92
  17      **3q**    5-Br   4-ClC~6~H~4~             12           93
  18      **3r**    5-Br   3-Cl-4-FC~6~H~3~         15           90
  19      **3s**    5-Br   4-BrC~6~H~4~             12           90
  20      **3t**    5-Br   3,5-(CH~3~)~2~C~6~H~3~   12           91
  21      **3u**    5-Br   *n*-C~4~H~9~             15           92

To expand the scope of the present method, *N*-substituted 3-aminocyclohex-2-enone, *N*-substituted 3-amino-5-phenylcyclohex-2-enones or *N*-substituted 3-amino-5-methylcyclohex-2-enones (**4**) were examined to replace the *N*-substituted 3-amino-5,5-dimethylcyclohex-2-enones (**2**), to our surprise, under the above optimized conditions, the desired 4,5-dihydropyrrolo\[2,3,4-*kl*\]acridine products **3** were not obtained. In the corresponding ^1^H-NMR spectra, the methylene group signals could not be detected, however a new aromatic proton could be detected easily. This result indicated that the corresponding oxidation products, the pyrrolo\[2,3,4-*kl*\]acridine derivatives **5** were produced ([Table 3](#molecules-18-01613-t003){ref-type="table"}). The reason is that when there is no substituent or only one substituene (phenyl or methyl) on the C~5~ position of *N*-substituted 3-aminocyclohex-2-enone, the 4,5-dihydropyrrolo\[2,3,4-*kl*\]acridine derivatives would be oxidized by oxygen in the air to give pyrrolo\[2,3,4-*kl*\]acridine derivatives. The reaction pathways could therefore be controlled by varying the enaminones with different substitution patterns to give a series of novel 4,5-dihydropyrrolo\[2,3,4-*kl*\]acridin-1-ones **3** and pyrrolo\[2,3,4-*kl*\]acridin-1-ones **5** selectively.

molecules-18-01613-t003_Table 3

###### 

Synthesis of pyrrolo\[2,3,4-*kl*\]acridine derivatives **5**.

  Entry   Product   R~1~   R~2~                     R~3~    Time (min)   Isolated Yield (%)
  ------- --------- ------ ------------------------ ------- ------------ --------------------
  1       **5a**    5-F    4-ClC~6~H~4~             H       15           87
  2       **5b**    5-F    2,4-Cl~2~C~6~H~3~        H       15           88
  3       **5c**    5-F    C~6~H~5~                 H       15           87
  4       **5d**    5-Cl   4-BrC~6~H~4~             H       15           88
  5       **5e**    5-F    4-*t*-BuC~6~H~4~         H       15           86
  6       **5f**    5-F    4-ClC~6~H~4~             Ph      15           87
  7       **5g**    5-F    3-Cl-4-FC~6~H~3~         Ph      15           84
  8       **5h**    H      C~6~H~5~                 Ph      15           88
  9       **5i**    5-F    2,4-(CH~3~)~2~C~6~H~3~   Ph      15           85
  10      **5j**    H      4-BrC~6~H~4~             Ph      15           87
  11      **5k**    5-Cl   4-*t*-BuC~6~H~4~         Ph      15           85
  12      **5l**    5-F    C~6~H~5~                 Ph      15           84
  13      **5m**    5-Br   4-CH~3~C~6~H~4~          Ph      15           85
  14      **5n**    5-Br   4-OCH~3~C~6~H~4~         CH~3~   15           85

The structures of the products **3** and **5**were identified from their IR, ^1^H-NMR, and HRMS spectra. The structure of compound **3k** was further confirmed by X-ray analysis ([Figure 1](#molecules-18-01613-f001){ref-type="fig"}).

![Molecular structure of compound **3k**.](molecules-18-01613-g001){#molecules-18-01613-f001}

3. Experimental
===============

3.1. General
------------

All reagents were purchased from commercial suppliers and used without further purification. Melting points are uncorrected. IR spectra were recorded on Varian F-1000 spectrometer in KBr with absorptions in cm^−1^. ^1^H-NMR (300 MHz or 400 MHz) spectra were recorded on a Varian Inova-300 MHz and Varian Inova-400 MHz (Palo Alto, CA, USA) in DMSO-*d~6~* or CDCl~3~ solution. *J* values are in Hertz. Chemical shifts are expressed in parts per million downfield from internal standard TMS. High-resolution mass spectra (HRMS) for all the compounds were determined on Bruker MicrOTOF-QII mass spectrometer with ESI resource (Billerica, MA, USA). X-ray crystallographic analysis was performed with a Rigaku Mercury CCD/AFC diffractometer (Tokyo, Japan). Microwave irradiation was carried out with an Initiator EXP Microwave Synthesizer from Biotage (Uppsala, Sweden). The reaction temperature was measured by an infrared detector during microwave heating.

3.2. General Procedure for the Synthesis of Compounds **3** and **5**
---------------------------------------------------------------------

Isatin (**1**, 1.0 mmol) was introduced in a 10-mL Initiator reaction vial, and enaminone **2** or **4** (1.0 mmol) and 0.02 g of silica sulfuric acid as well as ethanol (3 mL) were then successively added. Subsequently, the reaction vial was closed and prestirred for 10 s. The mixture was irradiated (time, 12 or 15 min; temperature, 110 °C; absorption level, high; fixed hold time) until TLC (petroleum ether/ethyl acetate 3:1) revealed that convension of the starting material **1** was complete. The reaction mixture was then cooled to room temperature and concentrated. The solid was collected by Büchner filtration and purified by flash column chromatography (silica gel, mixture of petroleum ether/ethyl acetate, 3:1, v/v) to afford the desired products **3** or **5**.

*2-(4-tert-Butylphenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3a**). M.p. 168--170 °C; IR (KBr, cm^−1^) 2930, 1690, 1448, 1332, 1075, 959, 891, 831, 700; ^1^H-NMR (400 MHz, DMSO-*d~6~*): *δ* (ppm) 1.28 (s, 6H, 2 × CH~3~), 1.34 (s, 9H, (CH~3~)~3~), 3.33 (s, 2H, CH~2~), 5.80 (s, 1H, CH), 7.44 (d, *J* = 8.4 Hz, 2H, ArH), 7.59 (d, *J* = 8.4 Hz, 2H, ArH), 7.77 (t, *J* = 7.6 Hz, 1H, ArH), 7.84--7.88 (m, 1H, ArH), 8.16 (d, *J* = 8.8 Hz, 1H, ArH), 8.57 (d, *J* = 8.0 Hz, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~27~N~2~O \[M+H\]^+^, 383.2123; found, 383.2103.

*4,5-Dihydro-4,4-dimethyl-2-(3,5-dimethylphenyl)pyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3b**). M.p. 205--207 °C; IR (KBr, cm^−1^) 3064, 1717, 1634, 1499, 1386, 1327, 1257, 1186, 1092, 1018, 777; ^1^H-NMR (400 MHz, DMSO-*d~6~*): *δ* (ppm) 1.20 (s, 6H, 2 × CH~3~), 2.30 (s, 6H, 2 × CH~3~), 3.07 (s, 2H, CH~2~), 5.64 (s, 1H, CH), 7.02--7.04 (m, 3H, ArH), 7.64 (t, *J* = 7.2 Hz, 1H, ArH), 7.72 (t, *J* = 7.6 Hz, 1H, ArH), 8.04 (d, *J* = 8.0 Hz, 1H, ArH), 8.46 (d, *J* = 7.6 Hz, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~23~N~2~O \[M+H\]^+^, 355.1810; found, 355.1811.

*2-(2-Ethylphenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3c**). M.p. 196--198 °C; IR (KBr, cm^−1^) 2957, 1708, 1646, 1500, 1348, 1146, 1083, 1016, 896, 830, 738; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.39--1.40 (m, 9H, 3 × CH~3~), 2.39--2.43 (m, 2H, CH~2~), 3.32 (s, 2H, CH~2~), 5.82 (s, 1H, CH), 7.33--7.39 (m, 2H, ArH), 7.59--7.60 (m, 1H, ArH), 7.73--7.82 (m, 3H, ArH), 8.27--8.30 (m, 1H, ArH), 8.72--8.74 (m, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~23~N~2~O \[M+H\]^+^, 355.1810; found, 355.1823.

*2-(3-Chloro-4-fluorophenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3d**). M.p. 168--169 °C; IR (KBr, cm^−1^) 2958, 1710, 1462, 1356, 1171, 1100, 880, 755; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.34 (s, 6H, 2 × CH~3~), 3.26 (s, 2H, CH~2~), 5.60 (s, 1H, CH), 7.31--7.38 (m, 2H, ArH), 7.56 (s, 1H, ArH), 7.69--7.78 (m, 2H, ArH), 8.20--8.21 (m, 1H, ArH), 8.69--8.70 (m, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~22~H~17~ClFN~2~O \[M+H\]^+^, 379.1013; found, 379.1015.

*9-Chloro-4,5-dihydro-2-(4-methoxyphenyl)-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3e**). M.p. 162--164 °C; IR (KBr, cm^−1^) 2954, 1704, 1494, 1342, 1121, 1009, 819; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.32 (s, 6H, 2 × CH~3~), 3.18 (s, 3H, OCH~3~), 3.87 (s, 2H, CH~2~), 5.59 (s, 1H, CH), 7.04 (d, *J* = 6.6 Hz, 2H, ArH), 7.38 (d, *J* = 6.6 Hz, 2H, ArH), 7.65 (d, *J* = 7.2 Hz, 1H, ArH), 8.05 (d, *J* = 8.7 Hz, 1H, ArH), 8.66 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~23~H~20~ClN~2~O~2~ \[M+H\]^+^, 391.1213; found, 391.1194.

*2-(4-Tert-butylphenyl)-9-chloro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3f**). M.p. 182--184 °C; IR (KBr, cm^−1^) 2947, 1575, 1485, 1392, 1319, 1253, 1077, 989, 833, 717; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.33 (s, 6H, 2 × CH~3~), 1.38 (s, 9H, (CH~3~)~3~), 3.19 (s, 2H, CH~2~), 5.68 (s, 1H, CH), 7.42 (s, 2H, ArH), 7.56--7.57 (m, 2H, ArH), 7.66--7.68 (m, 1H, ArH), 8.08--8.09 (m, 1H, ArH), 8.69 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~26~ClN~2~O \[M+H\]^+^, 417.1734; found, 417.1768.

*9-Chloro-4,5-dihydro-4,4-dimethyl-2-(3,5-dimethylphenyl)pyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3g**). M.p. 178--180 °C; IR (KBr, cm^−1^) 2928, 1705, 1636, 1521, 1474, 1396, 1254, 1176, 1109, 1035, 803; ^1^H-NMR (400 MHz, DMSO-*d~6~*): *δ* (ppm) 1.11 (s, 6H, 2 × CH~3~), 2.21 (s, 6H, 2 × CH~3~), 2.97 (s, 2H, CH~2~), 5.61 (s, 1H, CH), 6.94 (s, 3H, ArH), 7.61--7.65 (m, 1H, ArH), 7.91 (d, *J* = 8.8 Hz, 1H, ArH), 8.23 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~22~ClN~2~O \[M+H\]^+^, 389.1421; found, 389.1405.

*9-Chloro-2-(3-chloro-4-fluorophenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3h**). M.p. 164--166 °C; IR (KBr, cm^−1^) 2944, 1634, 1484, 1369, 1288, 1182, 1093, 951, 818, 693; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.34 (s, 6H, 2 × CH~3~), 3.20 (s, 2H, CH~2~), 5.63 (s, 1H, CH), 7.32--7.37 (m, 2H, ArH), 7.57 (s, 1H, ArH), 7.69 (d, *J* = 7.8 Hz, 1H, ArH), 8.09 (d, *J* = 7.8 Hz, 1H, ArH), 8.66 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~22~H~16~ Cl~2~FN~2~O \[M+H\]^+^, 413.0624; found: 413.0608.

*9-Chloro-2-(2-ethylphenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3i**). M.p. 198--200 °C; IR (KBr, cm^−1^) 2948, 1703, 1638, 1516, 1457, 1351, 1209, 1087, 910, 879, 804; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.14--1.16 (m, 3H, CH~3~), 1.31 (s, 6H, 2 × CH~3~), 2.56 (s, 2H, CH~2~), 3.20 (s, 2H, CH~2~), 5.29 (s, 1H, CH), 7.27 (s, 1H, ArH), 7.36 (s, 1H, ArH), 7.45 (s, 2H, ArH), 7.67 (d, *J* = 8.1 Hz, 1H, ArH), 8.09 (d, *J* = 6.9 Hz, 1H, ArH), 8.69 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~22~ClN~2~O \[M+H\]^+^, 389.1421; found, 389.1416.

*2-Butyl-9-chloro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3j**). M.p. 148--149 °C; IR (KBr, cm^−1^) 2950, 1706, 1500, 1346, 1240, 1091, 956, 890, 824, 697; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 0.92--0.94 (m, 3H, CH~3~), 1.29--1.36 (m, 8H, CH~2~ + 2 × CH~3~), 1.66--1.67 (m, 2H, CH~2~), 3.09--3.10 (m, 2H, CH~2~), 3.73--3.74 (m, 2H, CH~2~), 5.51 (s, 1H, CH), 7.57--7.58 (m, 1H, ArH), 7.96--7.98 (m, 1H, ArH), 8.56 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~20~H~22~ClN~2~O \[M+H\]^+^, 341.1421; found, 341.1412.

*2-(4-tert-Butylphenyl)-9-fluoro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3k**). M.p. 168--170 °C; IR (KBr, cm^−1^) 3079, 1711, 1635, 1504, 1403, 1256, 1119, 1063, 775, 707; ^1^H-NMR (400 MHz, DMSO-*d~6~*): *δ* (ppm) 1.24 (s, 6H, 2 × CH~3~), 2.38 (s, 3H, CH~3~), 3.08 (s, 2H, CH~2~), 5.70 (s, 1H, CH), 7.31--7.36 (m, 4H, ArH), 7.60 (s, 1H, ArH), 8.00--8.09 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~23~H~20~FN~2~O \[M+H\]^+^, 359.1560; found, 359.1544.

*2-(4-Chlorophenyl)-9-fluoro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3l**). M.p. 192--195 °C; IR (KBr, cm^−1^) 2957, 1703, 1508, 1360, 1223, 1110, 825, 699; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.32 (s, 6H, 2 × CH~3~), 3.19 (s, 2H, CH~2~), 5.63 (s, 1H, CH), 7.44--7.52 (s, 5H, ArH), 8.12--8.16 (m, 1H, ArH), 8.28--8.31 (m, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~22~H~17~ClFN~2~O \[M+H\]^+^, 379.1013; found, 379.1005.

*9-Fluoro-4,5-dihydro-4,4-dimethyl-2-(2,4-dimethylphenyl)pyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3m**). M.p. 148--150 °C; IR (KBr, cm^−1^) 2940, 1697, 1602, 1454, 1354, 1251, 1096, 970, 896, 834, 707; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.28 (s, 6H, 2 × CH~3~), 2.06 (s, 3H, CH~3~), 2.35 (s, 3H, CH~3~), 3.17 (s, 2H, CH~2~), 5.28 (s, 1H, CH), 7.13 (s, 1H, ArH), 7.24 (s, 2H, ArH), 7.46--7.48 (m, 1H, ArH), 8.12--8.14 (m, 1H, ArH), 8.28--8.31 (m, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~22~FN~2~O \[M+H\]^+^, 373.1716; found, 373.1699.

*2-(3-Chloro-4-fluorophenyl)-9-fluoro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3n**). M.p. 172--173 °C; IR (KBr, cm^−1^) 2958, 1613, 1473, 1363, 1273, 1171, 1070, 998, 910, 827, 701; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.33 (s, 6H, 2 × CH~3~), 3.22 (s, 2H, CH~2~), 5.63 (s, 1H, CH), 7.30--7.36 (m, 2H, ArH), 7.48--7.57 (m, 2H, ArH), 8.14--8.18 (m, 1H, ArH), 8.25--8.27 (m, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~22~H~16~ClF~2~N~2~O \[M+H\]^+^, 397.0919; found, 397.0927.

*2-(4-tert-Butylphenyl)-9-fluoro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3o**). M.p. 204--206 °C; IR (KBr, cm^−1^) 2950, 1707, 1639, 1493, 1348, 1201, 1086, 1017, 955, 833; ^1^H-NMR (400 MHz, DMSO-*d~6~*): *δ* (ppm) 1.19 (s, 6H, 2 × CH~3~), 1.27 (s, 9H, (CH~3~)~3~), 3.04 (s, 2H, CH~2~), 5.70 (s, 1H, CH), 7.36--7.37 (m, 2H, ArH), 7.51--7.59 (m, 3H, ArH), 7.97 (s, 1H, ArH), 8.07 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~26~FN~2~O \[M+H\]^+^, 401.2029; found, 401.2034.

*2-(2-Ethylphenyl)-9-fluoro-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3p**). M.p. 166--168 °C; IR (KBr, cm^−1^) 2949, 1699, 1514, 1353, 1196, 1098, 1017, 943, 843, 785; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.12--1.17 (m, 3H, CH~3~), 1.30 (s, 6H, 2 × CH~3~), 2.53--2.56 (m, 2H, CH~2~), 3.20 (s, 2H, CH~2~), 5.28 (s, 1H, CH), 7.27 (s, 1H, ArH), 7.35 (s, 1H, ArH), 7.44--7.46 (m, 2H, ArH), 7.50--7.53 (m, 1H, ArH), 8.15--8.18 (m, 1H, ArH), 8.33 (d, *J* = 6.3 Hz, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~22~FN~2~O \[M+H\]^+^, 373.1716; found, 373.1712.

*9-Bromo-2-(4-chlorophenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3q**). M.p. 192--194 °C; IR (KBr, cm^−1^) 2949, 1705, 1499, 1351, 1102, 961, 826, 740; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.32 (s, 6H, 2 × CH~3~), 3.17 (s, 2H, CH~2~), 5.64 (s, 1H, CH), 7.44--7.49 (m, 4H, ArH), 7.80 (s, 1H, ArH), 7.97 (s, 1H, ArH), 8.81 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~22~H~17~BrClN~2~O \[M+H\]^+^, 439.0213; found, 439.0197.

*9-Bromo-2-(3-chloro-4-fluorophenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3r**). M.p. 168--170 °C; IR (KBr, cm^−1^) 2950, 1704, 1588, 1495, 1439, 1347, 1084, 822, 702; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.33 (s, 6H, 2 × CH~3~), 3.18 (s, 2H, CH~2~), 5.63 (s, 1H, CH), 7.30--7.36 (m, 2H, ArH), 7.56 (s, 1H, ArH), 7.79 (d, *J* = 6.6 Hz, 1H, ArH), 7.98 (d, *J* = 8.4 Hz, 1H, ArH), 8.77 (s, 1H, CH). HRMS (ESI): *m/z* calcd. for C~22~H~16~BrClFN~2~O \[M+H\]^+^, 457.0119; found, 457.0103.

*9-Bromo-2-(4-bromophenyl)-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3s**). M.p. 182--184 °C; IR (KBr, cm^−1^)2955, 1709, 1590, 1459, 1343, 1159, 1013, 889, 832, 766, 705; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.32 (s, 6H, 2 × CH~3~), 3.18 (s, 2H, CH~2~), 5.64 (s, 1H, CH), 7.37--7.39 (m, 2H, ArH), 7.65 (s, 2H, ArH), 7.79--7.82 (m, 1H, ArH), 7.99 (d, *J* = 6.9 Hz, 1H, ArH), 8.82 (s, 1H, CH). HRMS (ESI): *m/z* calcd. for C~22~H~17~ Br~2~N~2~O \[M+H\]^+^, 482.9708; found, 482.9693.

*9-Bromo-4,5-dihydro-4,4-dimethyl-2-(3,5-dimethylphenyl)pyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3t**). M.p. 164--166 °C; IR (KBr, cm^−1^) 2958, 1915, 1612, 1550, 1445, 1318, 1229, 1101, 984, 823, 715; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.31 (s, 6H, 2 × CH~3~), 2.39 (s, 6H, 2 × CH~3~), 3.16 (s, 2H, CH~2~), 5.63 (s, 1H, CH), 7.03--7.07 (m, 3H, ArH), 7.22 (d, *J* = 6.0 Hz, 1H, ArH), 7.96--7.98 (m, 1H, ArH), 8.83 (s, 1H, CH). HRMS (ESI): *m/z* calcd. for C~24~H~22~BrN~2~O \[M+H\]^+^, 433.0916; found, 433.0906.

*9-Bromo-2-butyl-4,5-dihydro-4,4-dimethylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**3u**). M.p. 156--158 °C; IR (KBr, cm^−1^) 2938, 1699, 1510, 1450, 1356, 1245, 1126, 1028, 831, 789; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 0.95 (s, 3H, CH~3~), 1.32--138 (m, 8H, CH~2~ + 2 × CH~3~), 1.69--1.70 (m, 2H, CH~2~), 3.11--3.12 (m, 2H, CH~2~), 3.77 (s, 2H, CH~2~), 5.54 (s, 1H, CH), 7.74 (d, *J* = 7.2 Hz, 1H, ArH), 7.94 (d, *J* = 8.7 Hz, 1H, ArH), 8.78 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~20~H~22~BrN~2~O \[M+H\]^+^, 385.0916; found, 385.0917.

*2-(4-Chlorophenyl)-9-fluoropyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5a**). M.p. 237--238 °C; IR (KBr, cm^−1^) 3022, 1716, 1638, 1185, 1074, 874; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 7.02--7.04 (m, 1H, ArH), 7.56--7.59 (m, 4H, ArH), 7.69--7.73 (m, 2H, ArH), 7.90 (d, *J* = 9.2 Hz 1H, ArH), 8.44--8.50 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~20~H~10~ClFN~2~NaO, 371.0363, \[M+Na\]^+^; found, 371.0345.

*2-(2,4-Dichlorophenyl)-9-fluoropyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5b**). M.p. 248--250 °C; IR (KBr, cm^−1^) 3050, 1723, 1639, 1182, 1089, 785; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 6.66 (d, *J* = 6.8 Hz 1H, ArH), 7.43--7.45 (m, 1H, ArH), 7.58 (d, *J* = 8.0 Hz, 2H, ArH), 7.69--7.73 (m, 2H, ArH), 7.92 (d, *J* = 8.8 Hz 1H, ArH), 8.49--8.53 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~20~H~9~Cl~2~FN~2~NaO, 404.9974, \[M+Na\]^+^; found, 404.9989.

*9-Fluoro-2-phenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5c**). M.p. 228--230 °C; IR (KBr, cm^−1^) 2978, 1716, 1673, 1262, 1185, 1074, 874; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 7.03 (d, *J* = 6.8 Hz 1H, ArH), 7.46--7.47 (m, 1H, ArH), 7.60--7.76 (m, 6H, ArH), 7.87 (d, *J* = 8.8 Hz 1H, ArH), 8.43--8.50 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~20~H~11~FN~2~NaO, 337.0753, \[M+Na\]^+^; found, 337.0769.

*2-(4-Bromophenyl)-9-chloropyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5d**). M.p. 218--220 °C; IR (KBr, cm^−1^) 2978, 1706, 1632, 1503, 1130, 1118 1096, 854; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 6.70--6.71 (m, 1H, ArH), 7.48--7.59 (m, 3H, ArH), 7.64--7.71 (m, 3H, ArH), 7.87--7.89 (m, 1H, ArH), 8.43--8.49 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~20~H~10~BrClN~2~NaO, 430.5963, \[M+Na\]^+^; found, 430.5978.

*2-(4-tert-Butylphenyl)-9-fluoropyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5e**). M.p. 162--164 °C; IR (KBr, cm^−1^) 2951, 1710, 1628, 1512, 1353, 1205, 1096, 830, 718; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 1.42 (s, 9H, C(CH~3~)~3~), 7.04--7.06 (m, 1H, ArH), 7.57--7.71 (m, 6H, ArH), 7.85--7.89 (m, 1H, ArH), 8.44--8.51 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~24~H~20~FN~2~O, 370.1481, \[M+H\]^+^; found, 371.1537.

*2-(4-Chlorophenyl)-9-fluoro-4-phenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5f**). M.p. 238--240 °C; IR (KBr, cm^−1^) 2930, 2352, 1710, 1640, 1503, 1384, 1092, 805; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 7.46--7.69 (m, 11H, ArH), 8.04--8.05 (m, 1H, ArH), 8.41--8.42 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~15~ClFN~2~O, 425.0857, \[M+H\]^+^; found, 425.0846.

*2-(3-Chloro-4-fluorophenyl)-9-fluoro-4-phenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5g**). M.p. 230--232 °C; IR (KBr, cm^−1^) 3069, 2926, 2354, 1716, 1639, 1499, 1087, 812; ^1^H-NMR (300 MHz, CDCl~3~): *δ* (ppm) 7.29--7.54 (m, 6H, ArH), 7.70--7.76 (m, 4H, ArH), 8.01--8.02 (m, 1H, ArH), 8.42--8.45 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~14~ ClF~2~N~2~O, 443.0763 \[M+H\]^+^; found, 443.0770.

*2,4-Diphenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5h**). M.p. 220--221 °C; IR (KBr, cm^−1^) 2921, 1718, 1637, 1496, 1103, 1008, 761; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 7.27 (s, 1H, ArH), 7.45--7.53 (m, 4H, ArH), 7.60--7.73 (m, 6H, ArH), 7.80 (t, *J* = 8.0 Hz, 1H, ArH), 7.93 (t, *J* = 8.4 Hz, 1H, ArH), 8.06 (s, 1H, ArH), 8.42 (d, *J* = 8.8 Hz, 1H, ArH), 8.89 (d, *J* = 8.0 Hz, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~16~N~2~NaO, 395.1160 \[M+Na\]^+^; found, 395.1182.

*9-Fluoro-2-(2,4-dimethylphenyl)-4-phenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5i**). M.p. 188--190 °C; IR (KBr, cm^−1^) 2990, 1705, 1633, 1131, 1066, 854; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 2.08 (s, 3H, CH~3~), 2.26 (s, 3H, CH~3~), 6.72--6.73 (m, 1H, ArH), 7.03--7.16 (m, 3H, ArH), 7.22--7.29 (m, 3H, ArH), 7.47--7.49 (m, 3H, ArH), 7.82--7.84 (m, 1H, ArH), 8.22--8.27 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~28~H~20~FN~2~O, 419.1560, \[M+H\]^+^; found, 419.1559.

*2-(4-Bromophenyl)-4-phenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5j**). M.p. 234--235 °C; IR (KBr, cm^−1^) *ν*2987, 1703, 1636, 1501, 1253, 1181, 1085, 832. ^1^H-NMR (CDCl~3~-*d~1~*, 400 MHz) *δ* : 7.22 (s, 1H, ArH), 7.40--7.56 (m, 5H, ArH), 7.69--7.79 (m, 5H, ArH), 7.91 (t, *J* = 7.6 Hz, 1H, ArH), 8.05 (s, 1H, ArH), 8.40 (d, *J* = 8.8 Hz, 1H, ArH), 8.83 (d, *J* = 8.4 Hz, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~16~BrN~2~O, 451.0446, \[M+H\]^+^; found, 451.0409.

*2-(4-tert-Butylphenyl)-9-chloro-4-phenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5k**). M.p. 222--223 °C; IR (KBr, cm^−1^) 2922, 1719, 1634, 1383, 1171, 1077, 822; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 1.42 (s, 9H, (CH~3~)~3~), 7.19--7.22 (m, 1H, ArH), 7.42--7.68 (m, 9H, ArH), 7.75--7.80 (m, 1H, ArH), 7.92--7.96 (m, 1H, ArH), 8.27--8.31 (m, 1H, ArH), 8.73--8.78 (m, 1H, ArH) HRMS (ESI): *m/z* calcd. for C~30~H~24~ClN~2~O, 463.1577, \[M+H\]^+^; found, 463.1570.

*9-Fluoro-2,4-diphenylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5l**). M.p. 218--219 °C; IR (KBr, cm^−1^) 2957, 1705, 1633, 1322, 1173, 1096, 854; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 7.43--7.51 (m, 4H, ArH), 7.59--7.70 (m, 8H, ArH), 8.01--8.02 (m, 1H, ArH), 8.41--8.43 (m, 2H, ArH). HRMS (ESI): *m/z* calcd. for C~26~H~16~FN~2~O, 391.1247, \[M+H\]^+^; found, 391.1229.

*9-Bromo-4-phenyl-2-p-tolylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5m**). M.p. 220--222 °C; IR (KBr, cm^−1^) 2921, 1706, 1635, 1384, 1129, 1092, 820; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 2.45 (s, 3H, CH~3~), 7.17 (s, 1H, ArH), 7.38--7.50 (m, 7H, ArH), 7.65 (d, *J* = 7.6 Hz, 2H, ArH), 7.89--7.95 (m, 2H, ArH), 8.21 (d, *J* = 9.2 Hz, 1H, ArH), 8.98 (s, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~27~H~17~BrN~2~NaO, 487.0422, \[M+H\]^+^; found, 487.0403.

*9-Bromo-2-(4-methoxyphenyl)-4-methylpyrrolo\[2,3,4-kl\]acridin-1(2H)-one* (**5n**). M.p. 216--218 °C; IR (KBr, cm^−1^) 2916, 1718, 1637, 1516, 1384, 1124, 1080, 849; ^1^H-NMR (400 MHz, CDCl~3~): *δ* (ppm) 2.50 (s, 3H, CH~3~), 2.60 (s, 3H, OCH~3~), 6.82 (s, 1H, ArH), 7.41--7.60 (m, 5H, ArH), 7.93--7.96 (m, 1H, ArH), 8.24--8.26 (m, 1H, ArH), 9.03--9.04 (m, 1H, ArH). HRMS (ESI): *m/z* calcd. for C~22~H~15~BrN~2~NaO~2~, 441.0215, \[M+Na\]^+^; found, 441.0218.

4. Conclusions
==============

In conclusion, we have developed a procedure for the simple synthesis of a variety of potential biologically active pyrrolo\[2,3,4-*kl*\]acridines based on a novel domino reaction. Using this method, a library of molecularly diverse pyrrolo\[2,3,4-*kl*\]acridine derivatives was rapidly assembled (12--15 min) with excellent yields (84%--93%) by using readily available and inexpensive substrates under microwave irradiation.
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